Viewing Study NCT00442650

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 4:48 PM

Ignite Modification Date: 2025-12-27 @ 5:44 PM

Study NCT ID: NCT00442650

Status: COMPLETED

Last Update Posted: 2016-11-21

First Post: 2007-02-28

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis

Sponsor: Merck KGaA, Darmstadt, Germany

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module